Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. Founded by Hossein Ghanbari, Sensei Biotherapeutics is backed by investors that include Apeiron Investment Group, Presight Capital, Catalio Capital Management, Cambrian Biopharma, and Pura Vida Investments and is headquartered in Gaithersburg.
INDUSTRY:
Biotechnology, Health Diagnostics, Life Science, Medical, Therapeutics
FOUNDERS:
Hossein Ghanbari
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
